biotech
MedImmune Considers Sale
Filed in archive Corporate and Industrial News by ruth on April 13, 2007
MedImmune Considers Sale
MedImmune, the makers of the inhaled influenza vaccine FluMist, is considering acquisition offers from third parties. It has hired Goldman Sachs & Co. and the law firm Dewey Ballantine to help with a possible sale.
[snip].. indications of interest by major pharmaceutical companies, coupled with recent expressions by certain stockholders of dissatisfaction with the company's short-term stock price performance, have led the board to authorize management to gather information regarding possible strategic interest in acquiring the company.


More backgrounder info from Chron.com.

Permalink: MedImmune Considers Sale
Tags: MedImmune  investment  pharma  pharmaceutical  vaccine  FluMist  biotech  considers+sale 
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/63348
img Addthis img Ask img Blinklist img del.icio.us img Digg img Fark img Facebook img Google img Lycos img Ma.gnolia Add this page to Mister Wong Mr Wong img Netscape img Netvousz img Newsvine img Reddit img StumbleUpon img Slashdot img Tailrank img Technorati img Wink img Yahoo

Vote for MedImmune Considers Sale:

  • Currently 9.50/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 9.50 out of 2 vote(s) cast.
 
Subscribe
Share It
RSSrss
See all blog subscribe options
Google google
What is RSS?
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Newsletter

TwitterFollow us on Twitter!